Business Segments · Goodwill acquired

North American Pharmaceutical — Goodwill acquired

Year-over-year, this metric declined by 100.0%, from $250.00K to $0.00.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2025
Last reportedQ4 2026May 8, 2026

How to read this metric

An increase indicates active inorganic growth and investment in market share, while zero or low values suggest a focus on organic growth or lack of M&A activity.

Detailed definition

Represents the value of goodwill recognized during the acquisition of businesses within the North American pharmaceutica...

Peer comparison

Commonly reported by large-scale pharmaceutical wholesalers and healthcare distributors during periods of industry consolidation.

Metric ID: mck_segment_north_american_pharmaceutical_goodwill_acquired

Historical Data

6 periods
 Q1 '25Q2 '25Q3 '25Q4 '25Q3 '26Q4 '26
Value$250.00K$250.00K$250.00K$250.00K$0.00$0.00
QoQ Change+0.0%+0.0%+0.0%-100.0%
YoY Change-100.0%-100.0%
Range$0.00$250.00K
CAGR-100.0%
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Current Streak2 quarters decline

Frequently Asked Questions

What is McKesson's north american pharmaceutical — goodwill acquired?
McKesson (MCK) reported north american pharmaceutical — goodwill acquired of $0.00 in Q1 2026.
How has McKesson's north american pharmaceutical — goodwill acquired changed year-over-year?
McKesson's north american pharmaceutical — goodwill acquired decreased by 100.0% year-over-year, from $250.00K to $0.00.
What does north american pharmaceutical — goodwill acquired mean?
The value of intangible assets added through business acquisitions within the North American pharmaceutical segment.